Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PLA2G7 anticorps (AA 49-441) (HRP)

L’anticorps Lapin Polyclonal anti-PLA2G7 a été validé pour ELISA. Il convient pour détecter PLA2G7 dans des échantillons de Humain.
N° du produit ABIN7163619

Aperçu rapide pour PLA2G7 anticorps (AA 49-441) (HRP) (ABIN7163619)

Antigène

Voir toutes PLA2G7 (Lp-PLA2) Anticorps
PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Reactivité

  • 60
  • 22
  • 16
  • 15
  • 15
  • 2
  • 2
Humain

Hôte

  • 50
  • 19
  • 1
  • 1
Lapin

Clonalité

  • 51
  • 20
Polyclonal

Conjugué

  • 29
  • 10
  • 9
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PLA2G7 est conjugé à/à la HRP

Application

  • 56
  • 26
  • 24
  • 13
  • 13
  • 13
  • 11
  • 8
  • 6
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA
  • Épitope

    • 15
    • 11
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 49-441

     Réactivité croisée

    Humain

    Purification

    >95%, Protein G purified

    Immunogène

    Recombinant Human Platelet-activating factor acetylhydrolase protein (49-441AA)

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

    Autre désignation

    PLA2G7

    Sujet

    Background: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.

    Aliases: Platelet-activating factor acetylhydrolase precursor antibody, 1 alkyl 2 acetylglycerophosphocholine esterase antibody, 1-alkyl-2-acetylglycerophosphocholine esterase antibody, 2 acetyl 1 alkylglycerophosphocholine esterase antibody, 2-acetyl-1-alkylglycerophosphocholine esterase antibody, EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2 antibody, Group VIIA phospholipase A2 antibody, Group-VIIA phospholipase A2 antibody, gVIIA PLA2 antibody, gVIIA-PLA2 antibody, LDL associated phospholipase A2 antibody, LDL PLA(2) antibody, LDL PLA2 antibody, LDL-associated phospholipase A2 antibody, LDL-PLA(2) antibody, Lipoprotein associated phospholipase A2 antibody, LP PLA2 antibody, PAF 2 acylhydrolase antibody, PAF 2 acylhydrolase LDL associated phospholipase A2 antibody, PAF 2-acylhydrolase antibody, PAF acetylhydrolase antibody, PAFA_HUMAN antibody, PAFAD antibody, PAFAH antibody, Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma) antibody, PLA2G7 antibody, Platelet activating factor acetylhydrolase 2 antibody, Platelet activating factor acetylhydrolase antibody, Platelet-activating factor acetylhydrolase antibody

    UniProt

    Q13093

    Pathways

    Peptide Hormone Metabolism
Vous êtes ici:
Chat with us!